Hetero is one of the world leaders in developing and manufacturing a wide range of branded/non-branded generics. With a portfolio of more than 200 marketed products and 150 ANDAs filed across major therapeutic areas, the company is also the largest supplier of anti-retroviral drugs. Also, Hetero's vertically integrated API manufacturing capability makes generic formulations affordable.
Hetero’s range of generics includes solid and liquid oral dosages, pre-filled syringes, injectables, soft gelatin capsules, controlled-release and multi-layered tablets. Additionally, Hetero supports production of US DEA Schedule II controlled substance formulations.